Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kristen M Livesey

Showing results (1-10 of 19) with videos related to

Pageof 2
Sort By:
Oncology (Williston Park, N.Y.)|October 16, 2012
Breast cancer: never too young for a functional assessment?Gijsberta J Van Londen, Kristen M Livesey, Barry C Lembersky
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
Autophagy inhibition in combination cancer treatmentKristen M Livesey, Daolin Tang, Herbert J Zeh, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
Not just nuclear proteins: 'novel' autophagy cancer treatment targets - p53 and HMGB1Kristen M Livesey, Daolin Tang, Herbert J Zeh, et al.
Autophagy|October 12, 2010
HMGB1: a novel Beclin 1-binding protein active in autophagyRui Kang, Kristen M Livesey, Herbert J Zeh, et al.
Autophagy|June 1, 2012
Direct molecular interactions between HMGB1 and TP53 in colorectal cancerKristen M Livesey, Rui Kang, Herbert J Zeh, et al.
Antioxidants & Redox Signaling|March 15, 2011
High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stressDaolin Tang, Rui Kang, Kristen M Livesey, et al.
Autophagy|June 22, 2011
Metabolic regulation by HMGB1-mediated autophagy and mitophagyRui Kang, Kristen M Livesey, Herbert J Zeh, et al.
Autophagy|April 14, 2011
HMGB1 as an autophagy sensor in oxidative stressRui Kang, Kristen M Livesey, Herbert J Zeh, et al.
American Journal of Blood Research|March 21, 2012
HMGB1 is a therapeutic target for leukemiaYan Yu, Min Xie, Rui Kang, et al.
Antioxidants & Redox Signaling|December 4, 2010
The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injuryRui Kang, Daolin Tang, Kristen M Livesey, et al.
Pageof 2

Showing results (1-10 of 19) with videos related to

Sort By:
Pageof 2
Oncology (Williston Park, N.Y.)|October 16, 2012
Breast cancer: never too young for a functional assessment?Gijsberta J Van Londen, Kristen M Livesey, Barry C Lembersky
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2009
Autophagy inhibition in combination cancer treatmentKristen M Livesey, Daolin Tang, Herbert J Zeh, et al.
Current Opinion in Investigational Drugs (London, England : 2000)|November 28, 2008
Not just nuclear proteins: 'novel' autophagy cancer treatment targets - p53 and HMGB1Kristen M Livesey, Daolin Tang, Herbert J Zeh, et al.
Autophagy|October 12, 2010
HMGB1: a novel Beclin 1-binding protein active in autophagyRui Kang, Kristen M Livesey, Herbert J Zeh, et al.
Autophagy|June 1, 2012
Direct molecular interactions between HMGB1 and TP53 in colorectal cancerKristen M Livesey, Rui Kang, Herbert J Zeh, et al.
Antioxidants & Redox Signaling|March 15, 2011
High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stressDaolin Tang, Rui Kang, Kristen M Livesey, et al.
Autophagy|June 22, 2011
Metabolic regulation by HMGB1-mediated autophagy and mitophagyRui Kang, Kristen M Livesey, Herbert J Zeh, et al.
Autophagy|April 14, 2011
HMGB1 as an autophagy sensor in oxidative stressRui Kang, Kristen M Livesey, Herbert J Zeh, et al.
American Journal of Blood Research|March 21, 2012
HMGB1 is a therapeutic target for leukemiaYan Yu, Min Xie, Rui Kang, et al.
Antioxidants & Redox Signaling|December 4, 2010
The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injuryRui Kang, Daolin Tang, Kristen M Livesey, et al.
Pageof 2